(S (NP (NP (PRP$ His) (NN study)) (, ,) (SBAR (WHNP (WDT which)) (VP (VBD appeared) (PP (IN in) (NP (NP (NNP PharmacoEconomics)) (, ,) (NP (NP (DT an) (JJ international) (NN journal)) (PP (IN of) (NP (NP (ADJP (JJ economic) (CC and) (JJ quality)) (NN evaluation)) (PP (IN of) (NP (NN drug) (NN therapy)))))))))) (, ,)) (VP (VBD drew) (NP (PRP$ its) (NNS estimates)) (PP (IN from) (NP (NP (DT the) (NNS costs)) (PP (IN of) (NP (NP (JJ medical) (NNS problems)) (SBAR (WHNP (WDT that)) (VP (AUX have) (VP (AUX been) (VP (VBN tied) (PP (TO to) (NP (NP (NN obesity)) (, ,) (PP (VBG including) (NP (NP (NN cancer)) (, ,) (NP (JJ cardiovascular) (NN disease)) (, ,) (NP (JJ adult-onset) (NN diabetes)) (CC and) (NP (NN gallbladder) (NN disease))))))))))))))) (. .))
